About this trial
This randomized, single-blind, parallel-group controlled trial aims to investigate the effects of expiratory muscle training added to standard pulmonary rehabilitation on respiratory muscle strength, pulmonary function, cough effectiveness, exercise capacity, dyspnea perception, and quality of life in patients with non-cystic fibrosis bronchiectasis. Eligible patients aged 18-70 years with stable disease will be randomly assigned to either a pulmonary rehabilitation-only group or a pulmonary rehabilitation combined with expiratory muscle training group. Outcomes will be assessed at baseline and after completion of the intervention period.
Eligibility criteria
Qualifiers
Age between 18 and 70 years
Clinical diagnosis of non-cystic fibrosis bronchiectasis
Stable disease status
Follow-up at the Pulmonary Rehabilitation Unit of University of Health Sciences Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital
Disqualifiers
Acute exacerbation within the last 3 months
Diagnosis of cystic fibrosis-related bronchiectasis
Presence of severe cardiac, neurological, or orthopedic diseases that may interfere with exercise training
Cognitive impairment, lack of cooperation, or communication difficulties
Trial design
Treatments tested in this trial
- pulmonary rehabilitation
- Expiratory muscle training
Treatment groups
Sponsors and collaborators
Istanbul Demiroglu Bilim University
Lead sponsor
Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital
Collaborator